Additionally, IL-1β has a substantial role in lung cancer development via regulation of tumor growth, invasiveness, and angiogenesis, which were demonstrated in a clinical study using the anti-IL-1β antibody canakinumab [36]. The gene discussed is IL1B; the disease is lung carcinoma.